These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35278854)

  • 1. Pathogenetic Significance of YBX1 Expression in Acute Myeloid Leukemia Relapse.
    Gouda MBY; Hassan NM; Kandil EI; Haroun RA
    Curr Res Transl Med; 2022 Jul; 70(3):103336. PubMed ID: 35278854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of CEBPA mutations and BAALC expression in acute myeloid leukemia Egyptian patients with normal karyotype.
    El-Sharnouby JA; Ahmed LM; Taha AM; Kamal O
    Egypt J Immunol; 2008; 15(1):131-43. PubMed ID: 20306678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum MicroRNA-370 as a potential diagnostic and prognostic biomarker for pediatric acute myeloid leukemia.
    Lin X; Wang Z; Wang Y; Feng W
    Int J Clin Exp Pathol; 2015; 8(11):14658-66. PubMed ID: 26823789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. YBX1 mediates translation of oncogenic transcripts to control cell competition in AML.
    Perner F; Schnoeder TM; Xiong Y; Jayavelu AK; Mashamba N; Santamaria NT; Huber N; Todorova K; Hatton C; Perner B; Eifert T; Murphy C; Hartmann M; Hoell JI; Schröder N; Brandt S; Hochhaus A; Mertens PR; Mann M; Armstrong SA; Mandinova A; Heidel FH
    Leukemia; 2022 Feb; 36(2):426-437. PubMed ID: 34465866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact on acute myeloid leukemia relapse in granulocyte colony-stimulating factor application: a meta-analysis.
    Feng X; Lan H; Ruan Y; Li C
    Hematology; 2018 Oct; 23(9):581-589. PubMed ID: 29516766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCL3 Expression Is a Potential Prognostic and Predictive Biomarker in Acute Myeloid Leukemia of FAB Subtype M2.
    Niu Y; Yang X; Chen Y; Zhang L; Jin X; Tang Y; Li L; Yu L; Guo Y; Wang H
    Pathol Oncol Res; 2019 Apr; 25(2):541-548. PubMed ID: 30357752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow overexpression of SNAI1 is an early indicator of intrinsic drug resistance in patients with de novo acute myeloid leukemia.
    Gouda MBY; Hassan NM; Kandil EI
    J Gene Med; 2023 May; 25(5):e3443. PubMed ID: 35900907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YBX1 is required for maintaining myeloid leukemia cell survival by regulating BCL2 stability in an m6A-dependent manner.
    Feng M; Xie X; Han G; Zhang T; Li Y; Li Y; Yin R; Wang Q; Zhang T; Wang P; Hu J; Cheng Y; Gao Z; Wang J; Chang J; Cui M; Gao K; Chai J; Liu W; Guo C; Li S; Liu L; Zhou F; Chen J; Zhang H
    Blood; 2021 Jul; 138(1):71-85. PubMed ID: 33763698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypermethylation of the GATA binding protein 4 (GATA4) promoter in Chinese pediatric acute myeloid leukemia.
    Tao YF; Fang F; Hu SY; Lu J; Cao L; Zhao WL; Xiao PF; Li ZH; Wang NN; Xu LX; Du XJ; Sun LC; Li YH; Li YP; Xu YY; Ni J; Wang J; Feng X; Pan J
    BMC Cancer; 2015 Oct; 15():756. PubMed ID: 26490736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Significance of CD56 Antigen Expression in Patients with
    Sun Y; Wan J; Song Q; Luo C; Li X; Luo Y; Huang X; Ding R; Li H; Hou Y; Huang Y; Xie M; Huang Z; Zhang Y; Ma Y; Wu G; Xu S; Chen J
    Biomed Res Int; 2021; 2021():1929357. PubMed ID: 33928145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The outcomes of relapsed acute myeloid leukemia in children: Results from the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05R study.
    Moritake H; Tanaka S; Miyamura T; Nakayama H; Shiba N; Shimada A; Terui K; Yuza Y; Koh K; Goto H; Kakuda H; Saito A; Hasegawa D; Iwamoto S; Taga T; Adachi S; Tomizawa D
    Pediatr Blood Cancer; 2021 Jan; 68(1):e28736. PubMed ID: 32991072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of microRNA-375 is associated with poor prognosis in pediatric acute myeloid leukemia.
    Wang Z; Hong Z; Gao F; Feng W
    Mol Cell Biochem; 2013 Nov; 383(1-2):59-65. PubMed ID: 23864342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PIM-1 mRNA expression is a potential prognostic biomarker in acute myeloid leukemia.
    Cheng H; Huang C; Xu X; Hu X; Gong S; Tang G; Song X; Zhang W; Wang J; Chen L; Yang J
    J Transl Med; 2017 Aug; 15(1):179. PubMed ID: 28851457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct association of RUNX family expression with genetic alterations and clinical outcome in acute myeloid leukemia.
    Zhao Y; Zhang T; Zhao Y; Zhou J
    Cancer Biomark; 2020; 29(3):387-397. PubMed ID: 32741803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic inhibition of GAS6-AS1/YBX1/MYC axis suppresses cell propagation and disease progression of acute myeloid leukemia.
    Zhou H; Liu W; Zhou Y; Hong Z; Ni J; Zhang X; Li Z; Li M; He W; Zhang D; Chen X; Zhu J
    J Exp Clin Cancer Res; 2021 Nov; 40(1):353. PubMed ID: 34753494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical and biological prognostic factors in relapsed acute myeloid leukemia patients].
    Yébenes-Ramírez M; Serrano J; Martínez-Losada C; Sánchez-García J
    Med Clin (Barc); 2016 Sep; 147(5):185-191. PubMed ID: 27374030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lower expression of bone marrow miR-122 is an independent risk factor for overall survival in cytogenetically normal acute myeloid leukemia.
    Zhang TJ; Qian Z; Wen XM; Zhou JD; Li XX; Xu ZJ; Ma JC; Zhang ZH; Lin J; Qian J
    Pathol Res Pract; 2018 Jun; 214(6):896-901. PubMed ID: 29627222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of chromosomal abnormalities at relapse in children with relapsed acute myeloid leukemia: A retrospective cohort study of the Relapsed AML 2001/01 Study.
    Klein K; Beverloo HB; Zimmermann M; Raimondi SC; von Neuhoff C; de Haas V; van Weelderen R; Cloos J; Abrahamsson J; Bertrand Y; Dworzak M; Fynn A; Gibson B; Ha SY; Harrison CJ; Hasle H; Elitzur S; Leverger G; Maschan A; Razzouk B; Reinhardt D; Rizzari C; Smisek P; Creutzig U; Kaspers GJL
    Pediatr Blood Cancer; 2022 Jan; 69(1):e29341. PubMed ID: 34532968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation-independent ITGA2 overexpression is associated with poor prognosis in de novo acute myeloid leukemia.
    Lian XY; Zhang W; Wu DH; Ma JC; Zhou JD; Zhang ZH; Wen XM; Xu ZJ; Lin J; Qian J
    J Cell Physiol; 2018 Dec; 233(12):9584-9593. PubMed ID: 30132837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and prognostic relevance of long noncoding RNAs CRNDE and AOX2P in adult acute myeloid leukemia.
    Hola MAM; Ali MAM; ElNahass Y; Salem TAE; Mohamed MR
    Int J Lab Hematol; 2021 Aug; 43(4):732-742. PubMed ID: 34129278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.